Discounted Cash Flow Rating
Neutral
Return on Equity Rating
Sell
Debt to Equity Rating
Neutral
Price to Earnings Rating
Sell
Analyst Rating
Neutral
Wall Street Data Solutions Rating
Neutral
B
Aura Biosciences, Inc. Common Stock (AURA)
Biological Products, (no Disgnostic Substances)
https://www.aurabiosciences.com
Aura Biosciences Inc is a clinical-stage oncology company developing a novel technology platform based on virus-like drug conjugates to target and destroy cancer cells selectively while activating the immune system to create long-lasting anti-tumor immunity.
80 GUEST STREET
BOSTON, MA
Current Price
---.--
% Change Today
0.00%
Change Amt. Today
0.00
Active Status
Active
Listing Date
10/29/2021
Market Cap
391,228,656
Shares Outstanding
49,200,000
Weighted SO
49,259,879
Total Employees
N/A
Upcoming Earnings
N/A
Beta
0.3920
Last Div
0.0000
Range
5.99-12.35
Chg
-0.2833
Avg Vol
204196
Mkt Cap
391228656
Exch
NASDAQ
Country
US
Phone
617 500 8864
DCF Diff
7.3167
DCF
0.5433
Div Yield
0.0000
P/S
190.2863
EV Multiple
-4.3486
P/FV
2.0437
Div Yield %
0.0000
P/E
-4.8493
PEG
4.6310
Payout
0.0000
Current Ratio
18.5434
Quick Ratio
18.5434
Cash Ratio
2.8513
DSO
0.0000
DIO
0.0000
Op Cycle
0.0000
DPO
396.5264
CCC
-396.5264
Gross Margin
0.3468
Op Margin
-42.9815
Pretax Margin
-39.1552
Net Margin
-39.2442
Eff Tax Rate
0.0020
ROA
-0.3696
ROE
-0.4149
ROCE
-0.4254
NI/EBT
1.0023
EBT/EBIT
0.9110
EBIT/Rev
-42.9815
Debt Ratio
0.0872
D/E
0.0994
LT Debt/Cap
0.0784
Total Debt/Cap
0.0904
Int Coverage
-38.3218
CF/Debt
-3.8547
Equity Multi
1.1401
Rec Turnover
0.0000
Pay Turnover
0.9205
Inv Turnover
0.0000
FA Turnover
0.0957
Asset Turnover
0.0094
OCF/Share
-1.4808
FCF/Share
-1.5014
Cash/Share
3.7825
OCF/Sales
-35.6858
FCF/OCF
1.0139
CF Coverage
-3.8547
ST Coverage
-26.6412
CapEx Coverage
-71.9314
Div&CapEx Cov
-71.9314
P/BV
2.0437
P/B
2.0437
P/S
190.2863
P/E
-4.8493
P/FCF
-5.2592
P/OCF
-5.3328
P/CF
-5.3328
PEG
4.6310
P/S
190.2863
EV Multiple
-4.3486
P/FV
2.0437
DPS
0.0000
Latest Headlines (EST)
No Headlines Found